HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Chronic chemical respiratory disease — Clinical Guidelines

Overview

Chronic chemical respiratory disease encompasses a range of respiratory conditions exacerbated by chemical exposures, leading to persistent respiratory symptoms and impaired lung function. These conditions often require multidisciplinary management to mitigate symptoms and improve quality of life 1 2 3 29.

Diagnosis

Clinical Evaluation: History of chemical exposure and respiratory symptoms (cough, dyspnea, wheezing) 1 29.

Pulmonary Function Tests (PFTs): Spirometry to assess airflow obstruction and diffusing capacity to evaluate gas exchange 1 29.

Imaging: Chest X-rays or CT scans to identify structural changes or complications 1 29.

Microbiological Assessment: Consider sputum cultures and next-generation sequencing for microbiome analysis in pediatric cases 4.

Management

Vaccination: Annual influenza vaccination and pneumococcal vaccination for high-risk patients 1 9.

Pulmonary Rehabilitation: Multidisciplinary programs including exercise training, education, and psychological support 15 27.

Medication: Use of bronchodilators (e.g., short-acting beta-agonists, long-acting beta-agonists) and inhaled corticosteroids for symptom control 1 29.

Oxygen Therapy: Indicated for patients with hypoxemia, guided by home oxygen guidelines 19 28.

Environmental Control: Minimize exposure to harmful chemicals and improve indoor air quality 2 3 29.

Special Populations

Pediatrics: Consider microbiome analysis in chronic respiratory issues 4.

Elderly: Increased focus on frailty assessment and management in chronic lung disease 7.

Comorbidities: Address multimorbidity with tailored management plans, considering the interplay between chronic respiratory conditions and other chronic diseases 16.

Key Recommendations

Implement Routine Vaccinations: Annual influenza and pneumococcal vaccinations for patients with chronic respiratory diseases to prevent exacerbations (Evidence: Strong 1 9).

Engage in Pulmonary Rehabilitation: Offer structured pulmonary rehabilitation programs to improve exercise capacity and quality of life (Evidence: Strong 15 27).

Monitor and Manage Oxygen Therapy: Use home oxygen therapy based on evidence-based guidelines to manage hypoxemia effectively (Evidence: Moderate 19 28).

Assess Frailty in Older Adults: Regularly evaluate frailty in elderly patients with chronic lung disease to tailor care and reduce adverse outcomes (Evidence: Moderate 7).

Tailor Management for Multimorbidity: Develop individualized care plans addressing multiple chronic conditions concurrently (Evidence: Expert opinion 16).

References

1 de Miguel-Díez J, Torres-Castro R, Sanz Herrero F, Menéndez Villanueva R, Solís Gómez B, Quirós Fernández S et al.. SEPAR Recommendations on Vaccination for Chronic Respiratory Patients. Archivos de bronconeumologia 2026. link 2 Bao YQ, Fu M, Yu LH, Qun L, Lei YP, Li JJ et al.. Construction of Medical Device-Related Pressure Injury Risk Assessment Tool for Pulmonary and Critical Care Medicine: A Multi-Centre Prospective Study. International wound journal 2025. link 3 Hall K, Pilgrim H, Ehren J, Brown M, Barry R, Kelly R et al.. Student-delivered pulmonary and cardiac rehabilitation: Feasible, effective, and supports new care models. Respiratory medicine 2025. link 4 Campbell S, Gerasimidis K, Milling S, Dicker AJ, Hansen R, Langley RJ. The lower airway microbiome in paediatric health and chronic disease. Paediatric respiratory reviews 2024. link 5 Tang M, Liu W, Li H, Li F. Greenness and chronic respiratory health issues: a systematic review and meta-analysis. Frontiers in public health 2023. link 6 Kawaguchi K, Asai A, Mikawa R, Ogiso N, Sugimoto M. Age-related changes in lung function in National Center for Geriatrics and Gerontology Aging Farm C57BL/6N mice. Experimental animals 2023. link 7 Osadnik CR, Brighton LJ, Burtin C, Cesari M, Lahousse L, Man WDC et al.. European Respiratory Society statement on frailty in adults with chronic lung disease. The European respiratory journal 2023. link 8 Groot B, Dedding C, Slob E, Maitland H, Teunissen T, Rutjes N et al.. Adolescents' experiences with patient engagement in respiratory medicine. Pediatric pulmonology 2021. link 9 Papazoglou DD, Baretella O, Feller M, Del Giovane C, Moutzouri E, Aujesky D et al.. Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients. PloS one 2021. link 10 Jahnz-Różyk K, Czajkowska-Malinowska M, Krenke K, Sands D, Batura-Gabryel H, Kabicz P et al.. Analysis of hospital management of chronic respiratory diseases in light of the "Maps of Health Needs" project in Poland. Advances in respiratory medicine 2020. link 11 Balakrishnan S, Rakesh PS, Jayasankar S, Sunilkumar M, Krishnaveni V, Gopal B et al.. Lung Health Care pilot project trims patient pill load and antibiotic prescription in primary health care settings in Kerala, India. The Indian journal of tuberculosis 2020. link 12 Popov TA, Kralimarkova TZ, Labor M, Plavec D. The added value of exhaled breath temperature in respiratory medicine. Journal of breath research 2017. link 13 Longhurst C. Nurses struggle to help pupils with long-term conditions. Nursing children and young people 2016. link 14 Kurpas D, Szwamel K, Mroczek B. Quality of Care for Patients with Chronic Respiratory Diseases: Data for Accreditation Plan in Primary Healthcare. Advances in experimental medicine and biology 2016. link 15 Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder JA et al.. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. The European respiratory journal 2016. link 16 Morrison D, Agur K, Mercer S, Eiras A, González-Montalvo JI, Gruffydd-Jones K. Managing multimorbidity in primary care in patients with chronic respiratory conditions. NPJ primary care respiratory medicine 2016. link 17 Chakaya JM, Carter EJ, Hopewell PC. Pulmonary specialty training to improve respiratory health in low- and middle-income countries. Needs and challenges. Annals of the American Thoracic Society 2015. link 18 Soler-Cataluña JJ, Sánchez Toril F, Aguar Benito MC. The role of pulmonology in the National Health System Chronicity Strategy. Archivos de bronconeumologia 2015. link 19 Hardinge M, Annandale J, Bourne S, Cooper B, Evans A, Freeman D et al.. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015. link 20 Escarrabill J, Tebé C, Espallargues M, Torrente E, Tresserras R, Argimón J. Variability in home mechanical ventilation prescription. Archivos de bronconeumologia 2015. link 21 Vázquez-García JC, Salas-Hernández J, Pérez Padilla R, Montes de Oca M. Respiratory health in Latin America: number of specialists and human resources training. Archivos de bronconeumologia 2014. link 22 Spruit MA, Pitta F, Garvey C, ZuWallack RL, Roberts CM, Collins EG et al.. Differences in content and organisational aspects of pulmonary rehabilitation programmes. The European respiratory journal 2014. link 23 Kang SC, Pai FT, Hwang SJ, Tsao HM, Liou DM, Lin IF. Noncancer hospice care in taiwan: a nationwide dataset analysis from 2005 to 2010. Journal of palliative medicine 2014. link 24 Gabe ME, Murphy F, Davies GA, Russell IT, Jordan S. Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile. PloS one 2014. link 25 Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C et al.. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American journal of respiratory and critical care medicine 2013. link 26 Boucault R, Fernandes M, Oliveira Carvalho V. Six-minute walking test in children. Disability and rehabilitation 2013. link 27 Ambrosino N, Janah N, Gabbrielli L. Assessing the benefits: outcome and future directions. European journal of physical and rehabilitation medicine 2011. link 28 McDonald CF, Crockett AJ. Optimising the therapeutic use of oxygen in Australia. The Medical journal of Australia 2009. link 29 Lynes D, Kelly C. The psychological needs of patients with chronic respiratory disease. Nursing times 2003. link 30 Make BJ, Gilmartin ME. Rehabilitation and home care for ventilator-assisted individuals. Clinics in chest medicine 1986. link 31 Charnley RM, Verma R. Inhalation of a minitracheotomy tube. Intensive care medicine 1986. link 32 Conder JW. Health and safety information for regulatory purposes--an industrial point of view. Journal of chemical information and computer sciences 1979. link 33 McMichael AJ, Gerber WS, Gamble JF, Lednar WM. Chronic respiratory symptoms and job type within the rubber industry. Journal of occupational medicine. : official publication of the Industrial Medical Association 1976. link

Chronic chemical respiratory disease